Biosig Technologies, Inc. (BSGM) CEO Purchases $37,230.00 in Stock

Biosig Technologies, Inc. (NASDAQ:BSGM) CEO Kenneth L. Londoner acquired 8,500 shares of the company’s stock in a transaction on Thursday, January 10th. The shares were bought at an average cost of $4.38 per share, with a total value of $37,230.00. The purchase was disclosed in a document filed with the SEC, which is available through this hyperlink.

Shares of BSGM traded down $0.02 during midday trading on Friday, hitting $4.21. 40,028 shares of the company traded hands, compared to its average volume of 22,212. Biosig Technologies, Inc. has a 52 week low of $3.21 and a 52 week high of $7.88.

BSGM has been the subject of several research reports. Zacks Investment Research raised shares of Biosig Technologies from a “sell” rating to a “hold” rating in a report on Wednesday, December 5th. Roth Capital initiated coverage on shares of Biosig Technologies in a report on Thursday, December 6th. They set a “buy” rating and a $14.00 price objective for the company.

ILLEGAL ACTIVITY WARNING: This report was published by Sports Perspectives and is owned by of Sports Perspectives. If you are reading this report on another publication, it was illegally copied and republished in violation of United States and international trademark & copyright legislation. The legal version of this report can be viewed at

About Biosig Technologies

BioSig Technologies, Inc, a development stage medical device company, engages in developing a proprietary biomedical signal processing technology platform to extract information from physiologic signals. Its product is PURE (Precise Uninterrupted Real-time evaluation of Electrograms) EP System, a surface electrocardiogram and intracardiac multichannel recording and analysis system that acquires, processes, and displays electrocardiogram and electrograms required during electrophysiology studies and catheter ablation procedures.

Featured Article: What is net income?

Insider Buying and Selling by Quarter for Biosig Technologies (NASDAQ:BSGM)

Receive News & Ratings for Biosig Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Biosig Technologies and related companies with's FREE daily email newsletter.

Leave a Reply